Short-term (2-week) effects of discontinuing milnacipran in patients with fibromyalgia

Abstract

Objective:

To examine the effects of abruptly withdrawing milnacipran during the 2-week discontinuation phase of a study in which FM patients had received 12 weeks of stable-dose treatment with milnacipran at 100?mg/day.